Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT04931134
NA

Treatment of Anxiety Disorders With Trigeminal Nerve Stimulation

Sponsor: Dr. Rafael Freire

View on ClinicalTrials.gov

Summary

Primary objectives: The primary objective is to ascertain if trigeminal nerve stimulation is an effective treatment with high tolerability for patients with panic disorder, generalized anxiety disorder and social anxiety disorder.

Official title: Trigeminal Nerve Stimulation in Anxiety Disorders: a Randomized Controlled Trial

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

1

Start Date

2022-02-07

Completion Date

2026-01-31

Last Updated

2025-04-08

Healthy Volunteers

No

Interventions

DEVICE

Trigeminal nerve stimulation - active

Active trigeminal nerve stimulation

DEVICE

Trigeminal nerve stimulation - sham

Sham trigeminal nerve stimulation

Locations (1)

Kingston Health Sciences Centre

Kingston, Ontario, Canada